Stealth BioTherapeutics Corp logo
Stealth BioTherapeutics Corp MITO

Annual report 2021
added 12-23-2023

report update icon

Stealth BioTherapeutics Corp Income Statement 2011-2026 | MITO

Annual Income Statement Stealth BioTherapeutics Corp

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

450 M 47.9 M 78.9 M - - - - - - - -

Shares

682 M 31.3 M 31.3 M - - - - - - - -

Historical Prices

0.66 1.53 2.52 - - - - - - - -

Net Income

-52.5 M -57.5 M -71.7 M -96.7 M -82.9 M -61 M - - - - -

Revenue

- - 21.1 M - - - - - - - -

Operating Income

-46.3 M -48.7 M -45.8 M -75.3 M -79.7 M -61.8 M - - - - -

Interest Expense

1.24 M 1.81 M 6.67 M 21.4 M 3.28 M - - - - - -

EBITDA

-46.2 M -48.4 M -45.5 M -75 M -79.4 M -60.7 M - - - - -

Operating Expenses

46.3 M - 66.9 M - - - - - - - -

General and Administrative Expenses

19.7 M 19.4 M 22.3 M 22.2 M 16.5 M 13.4 M - - - - -

All numbers in USD currency

Quarterly Income Statement Stealth BioTherapeutics Corp

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - 712 M - - - 635 M 599 M - - 437 M - - - 68.5 M - - - 68.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

The income statement is one of the three key financial reports of a company Stealth BioTherapeutics Corp (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Biotechnology industry

Issuer Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M germanyGermany
Aquestive Therapeutics Aquestive Therapeutics
AQST
$ 4.14 0.36 % $ 443 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
$ 8.41 4.73 % $ 230 M israelIsrael
Ardelyx Ardelyx
ARDX
$ 6.06 1.94 % $ 1.46 B usaUSA
argenx SE argenx SE
ARGX
$ 752.35 0.79 % $ 25 B niderlandNiderland
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
$ 23.83 0.85 % $ 3.03 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
$ 2.65 -1.12 % $ 16.6 M usaUSA
I-Mab I-Mab
IMAB
- - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M franceFrance
BioCardia BioCardia
BCDA
$ 1.2 -0.04 % $ 8 M usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
$ 9.6 6.37 % $ 1.98 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$ 9.48 -3.27 % $ 613 M usaUSA
BioVie BioVie
BIVI
$ 1.45 2.09 % $ 2.14 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
- - $ 10.1 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
$ 2.32 4.98 % $ 908 M israelIsrael
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - russiaRussia
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
$ 56.49 1.78 % $ 10.8 B usaUSA
BioNTech SE BioNTech SE
BNTX
$ 92.3 1.23 % $ 27.2 B germanyGermany
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
- 3.16 % $ 1.9 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
- - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
- 10.36 % $ 9.8 M usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
$ 3.04 1.54 % $ 259 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
$ 1.16 -2.12 % $ 14.2 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
$ 4.54 9.54 % $ 683 M britainBritain
Cabaletta Bio Cabaletta Bio
CABA
$ 3.2 7.94 % $ 322 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 3.21 4.56 % $ 6.98 B israelIsrael
Aravive Aravive
ARAV
- -13.39 % $ 1.45 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
$ 19.97 2.94 % $ 1.78 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
- -39.0 % $ 4.57 M usaUSA
Codexis Codexis
CDXS
$ 1.97 7.97 % $ 172 M usaUSA
Cerus Corporation Cerus Corporation
CERS
$ 1.91 2.42 % $ 364 M usaUSA
Cullinan Management Cullinan Management
CGEM
$ 15.4 6.72 % $ 928 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
$ 1.75 0.87 % $ 205 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M germanyGermany
AstraZeneca PLC AstraZeneca PLC
AZN
- - $ 96.9 B britainBritain